Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 351 - 400 of 759 results
- Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin.
- Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
- Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction.
- Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
- Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.
- Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha.
- Sildenafil improves walk distance in idiopathic pulmonary fibrosis.
- FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat.
- Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction--an open, randomized cross-over study with flexible dosing.
- Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes.
- Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
- Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction.
- Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
- Proteomic analysis of rat penile tissue in a model of erectile dysfunction after radical prostatectomy.
- Antisense and Short Hairpin RNA (shRNA) Constructs Targeting PIN (Protein Inhibitor of NOS) Ameliorate Aging-Related Erectile Dysfunction in the Rat.
- An angiotensin II receptor blocker increases sexual behavior in type 2 diabetic mice.
- Characterization of a novel ATP-sensitive K(+) channel opener, A-251179, on urinary bladder relaxation and cystometric parameters.
- Antisense Oligodeoxynucleotides for Estrogen Receptor-beta and alpha Attenuate Estradiol's Modulation of Affective and Sexual Behavior, Respectively.
- Comparison of prevalence between self-reported erectile dysfunction and erectile dysfunction as defined by five-item International Index of Erectile Function in Taiwanese men older than 40 years.
- Rho-kinase inhibition suppresses potassium chloride-induced bladder hyperactivity in a rat model.
- Sphingosine-1-phosphate and the immunosuppressant, FTY720-phosphate, regulate detrusor muscle tone.
- Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence.
- Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
- Long-term results of three different minimally invasive therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: Comparison at a single institute.
- Can sildenafil treat primary premature ejaculation? A prospective clinical study.
- Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
- Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
- Antioxidant Treatment Associated with Sildenafil Reduces Monocyte Activation and Markers of Endothelial Damage in Patients with Diabetic Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study.
- Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety.
- A Rational Combination Pharmacotherapy in Men with Erectile Dysfunction who Initially Failed to Oral Sildenafil Citrate Alone: A Pilot Study.
- An alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate glutamate-receptor antagonist can inhibit premicturition contractions in rats with bladder outlet obstruction.
- Treatment of overactive bladder: Selective use of anticholinergic agents with low drug-drug interaction potential. .
- The prevalence of erectile dysfunction among hypertensive and prehypertensive men aged 25-40 years.
- PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: A prospective, randomized, placebo- and drug-controlled study.
- Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: Immunocytochemistry, autoradiography and behavioral studies.
- Efficacy of Botulinum Toxin-A for Treating Idiopathic Detrusor Overactivity: Results From a Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
- Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
- Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial.
- Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
- A novel mouse model for assessment of male sexual function.
- (Phenylpiperidinyl)cyclohexylsulfonamides: Development of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
- A-272651, a nonpeptidic blocker of large-conductance Ca(2+)-activated K(+) channels, modulates bladder smooth muscle contractility and neuronal action potentials.
- Estrogen receptor {beta}-deficient female mice develop a bladder phenotype resembling human interstitial cystitis.
- Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis.
- The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder.
- Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
- Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
- 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.
- Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists.
- Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.